BMS-986484 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Non-Small Cell Lung Cancer.

Zolacabtagene autoleucel is under clinical development by Bristol-Myers Squibb and currently in Phase I for Marginal Zone B-cell Lymphoma.

Regeneron Pharmaceuticals is a strong investment with robust growth potential, fueled by FDA approvals and resilient market ...

The FDA approved subcutaneous nivolumab for solid tumors, tiselizumab for advanced gastric and GEJ cancers, and key 2024 breast cancer breakthroughs are reviewed. Experts provide perspective on ...

The biggest change to Bristol is coming - the biggest since the aftermath of the Second World War - and most people don’t ...

Russia and other hostile states have become increasingly brazen in adopting “gray zone” attacks against Europe and the United States, leaving defense officials with a dilemma: How to respond ...

New year, new food? Here’s what to know about the top diets of 2025 New year, new food? Here’s what to know about the top diets of 2025 As 2025 arrives, experts break down the trending diets ...

A Brazilian influencer whose staggering 32-stone weight loss made him the star of a reality TV show has died aged 37 after piling on the pounds again following the loss of his dad and brother ...

Federal Reserve Bank of San Francisco President Mary Daly and Federal Reserve Board Governor Adriana Kugler speak as they attend the American Economics Association's annual conference, in San ...

The PA’s ban on Al Jazeera is part of a broader crackdown on those criticising its operation in the Jenin camp.

Beauty was extremely important in ancient Greece and not just for women but for men, as well. As admirers of beauty, ancient Greeks placed great emphasis on healthy skin, and, naturally, they ...